HDAC9 and brain ischemia: Previous studies have revealed that HDAC inhibition provides a statistically significant protection in Alzheimer’s disease, cerebral ischemia or ischemia/reperfusion model (Shein and Shohami, 2011; Ganai et al., 2016).